Bio-Rad Laboratories, Inc. (NYSE: BIO; BIO.B) has completed its exchange offer of up to $300 million in aggregate principal amount of its 8.00% Senior Subordinated Notes due 2016 that were registered under the Securities Act of 1933, for any and all of its outstanding 8.00% Senior Subordinated Notes due 2016 that were issued in a private placement. All of the outstanding $300 million of private notes were tendered and received before the expiration of the exchange offer at 5:00pm (EST), on February 4, 2010.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostics markets.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
